Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $62 at Oppenheimer Following NDR
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $62.00 (from $55.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
